93 related articles for article (PubMed ID: 10601663)
1. Biochemical characterization of different conformational states of the Sf9 cell-purified p53His175 mutant protein.
Cohen PA; Hupp TR; Lane DP; Daniels DA
FEBS Lett; 1999 Dec; 463(1-2):179-84. PubMed ID: 10601663
[TBL] [Abstract][Full Text] [Related]
2. The N terminus of the murine p53 tumour suppressor is an independent regulatory domain affecting activation and thermostability.
Hansen S; Lane DP; Midgley CA
J Mol Biol; 1998 Jan; 275(4):575-88. PubMed ID: 9466932
[TBL] [Abstract][Full Text] [Related]
3. Allosteric regulation of the thermostability and DNA binding activity of human p53 by specific interacting proteins. CRC Cell Transformation Group.
Hansen S; Hupp TR; Lane DP
J Biol Chem; 1996 Feb; 271(7):3917-24. PubMed ID: 8632013
[TBL] [Abstract][Full Text] [Related]
4. Wild-type p53 adopts a 'mutant'-like conformation when bound to DNA.
Halazonetis TD; Davis LJ; Kandil AN
EMBO J; 1993 Mar; 12(3):1021-8. PubMed ID: 8458320
[TBL] [Abstract][Full Text] [Related]
5. Expression of different conformations of p53 in the blast cells of acute myeloblastic leukaemia is related to in vitro growth characteristics.
Zhu YM; Bradbury D; Russell N
Br J Cancer; 1993 Nov; 68(5):851-5. PubMed ID: 8217600
[TBL] [Abstract][Full Text] [Related]
6. The characterisation of p53 binding phage isolated from phage peptide display libraries.
Daniels DA; Lane DP
J Mol Biol; 1994 Nov; 243(4):639-52. PubMed ID: 7966288
[TBL] [Abstract][Full Text] [Related]
7. On the mechanism of sequence-specific DNA-dependent acetylation of p53: the acetylation motif is exposed upon DNA binding.
Cesková P; Chichger H; Wallace M; Vojtesek B; Hupp TR
J Mol Biol; 2006 Mar; 357(2):442-56. PubMed ID: 16438982
[TBL] [Abstract][Full Text] [Related]
8. Evidence for allosteric effects on p53 oligomerization induced by phosphorylation.
Muller P; Chan JM; Simoncik O; Fojta M; Lane DP; Hupp T; Vojtesek B
Protein Sci; 2018 Feb; 27(2):523-530. PubMed ID: 29124793
[TBL] [Abstract][Full Text] [Related]
9. A significant decrease of the transcriptional activity of p53 mutants deriving from human functional adrenal tumors.
Lin SR; Yang YC; Jung JH; Tsai JH
DNA Cell Biol; 1996 Oct; 15(10):793-803. PubMed ID: 8892752
[TBL] [Abstract][Full Text] [Related]
10. A PAb240+ conformation of wild type p53 binds DNA.
McLure KG; Lee PW
Oncogene; 1996 Sep; 13(6):1297-303. PubMed ID: 8808704
[TBL] [Abstract][Full Text] [Related]
11. Wild-type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukaemic cells.
Zhu YM; Bradbury DA; Russell NH
Br J Cancer; 1994 Mar; 69(3):468-72. PubMed ID: 8123475
[TBL] [Abstract][Full Text] [Related]
12. Precise characterisation of monoclonal antibodies to the C-terminal region of p53 protein using the PEPSCAN ELISA technique and a new non-radioactive gel shift assay.
Pospísilová S; Brázda V; Amrichová J; Kamermeierová R; Palecek E; Vojtesek B
J Immunol Methods; 2000 Apr; 237(1-2):51-64. PubMed ID: 10725451
[TBL] [Abstract][Full Text] [Related]
13. Hyperphosphorylation of p53 induced by okadaic acid attenuates its transcriptional activation function.
Zhang W; McClain C; Gau JP; Guo XY; Deisseroth AB
Cancer Res; 1994 Aug; 54(16):4448-53. PubMed ID: 8044794
[TBL] [Abstract][Full Text] [Related]
14. Mdm2 binding to a conformationally sensitive domain on p53 can be modulated by RNA.
Burch LR; Midgley CA; Currie RA; Lane DP; Hupp TR
FEBS Lett; 2000 Apr; 472(1):93-8. PubMed ID: 10781812
[TBL] [Abstract][Full Text] [Related]
15. Modulation of p53 protein conformation and DNA-binding activity by intracellular chelation of zinc.
Verhaegh GW; Parat MO; Richard MJ; Hainaut P
Mol Carcinog; 1998 Mar; 21(3):205-14. PubMed ID: 9537652
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation studies on rat p53 using the baculovirus expression system. Manipulation of the phosphorylation state with okadaic acid and influence on DNA binding.
Fuchs B; Hecker D; Scheidtmann KH
Eur J Biochem; 1995 Mar; 228(3):625-39. PubMed ID: 7737156
[TBL] [Abstract][Full Text] [Related]
17. Biological significance of a small highly conserved region in the N terminus of the p53 tumour suppressor protein.
Liu WL; Midgley C; Stephen C; Saville M; Lane DP
J Mol Biol; 2001 Nov; 313(4):711-31. PubMed ID: 11697899
[TBL] [Abstract][Full Text] [Related]
18. Specific DNA binding by different classes of human p53 mutants.
Rolley N; Butcher S; Milner J
Oncogene; 1995 Aug; 11(4):763-70. PubMed ID: 7651740
[TBL] [Abstract][Full Text] [Related]
19. Preferential binding of tumor suppressor p53 to positively or negatively supercoiled DNA involves the C-terminal domain.
Mazur SJ; Sakaguchi K; Appella E; Wang XW; Harris CC; Bohr VA
J Mol Biol; 1999 Sep; 292(2):241-9. PubMed ID: 10493872
[TBL] [Abstract][Full Text] [Related]
20. Allosteric activation of latent p53 tetramers.
Hupp TR; Lane DP
Curr Biol; 1994 Oct; 4(10):865-75. PubMed ID: 7850419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
